Morgan Stanley Delcath Systems, Inc. Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Morgan Stanley holds 253,015 shares of DCTH stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

253,015

Previous 457,440 44.69%

Holding current value

$2.26 Million

Previous $6.22 Million 56.29%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$10.01 - $12.76 $2.05 Million - $2.61 Million	-204,425 Reduced 44.69%	253,015 $2.72 Million
Q2 2025 Aug 15, 2025	BUY	$10.39 - $18.1 $1.19 Million - $2.07 Million	114,309 Added 33.31%	457,440 $6.22 Million
Q1 2025 May 15, 2025	BUY	$11.43 - $16.45 $1.96 Million - $2.81 Million	171,109 Added 99.47%	343,131 $4.37 Million
Q4 2024 Feb 14, 2025	BUY	$8.32 - $12.64 $545,342 - $828,501	65,546 Added 61.56%	172,022 $2.03 Million
Q3 2024 May 14, 2025	BUY	$7.36 - $11.0 $24,604 - $36,773	3,343 Added 3.24%	106,476 $961,000
Q3 2024 Nov 14, 2024	BUY	$7.36 - $11.0 $24,604 - $36,773	3,343 Added 3.24%	106,476 $961,000
Q2 2024 May 14, 2025	SELL	$4.47 - $8.37 $307,933 - $576,600	-68,889 Reduced 40.05%	103,133 $863,000
Q2 2024 Oct 17, 2024	BUY	$4.47 - $8.37 $37,275 - $69,797	8,339 Added 8.8%	103,133 $863,000
Q2 2024 Aug 14, 2024	BUY	$4.47 - $8.37 $37,275 - $69,797	8,339 Added 8.8%	103,133 $863,000
Q1 2024 Oct 17, 2024	SELL	$3.72 - $5.09 $31,021 - $42,445	-8,339 Reduced 8.09%	94,794 $452,000
Q1 2024 Aug 16, 2024	BUY	$3.72 - $5.09 $43,896 - $60,062	11,800 Added 14.22%	94,794 $452,000
Q1 2024 May 15, 2024	BUY	$3.72 - $5.09 $43,896 - $60,062	11,800 Added 14.22%	94,794 $452,000
Q4 2023 Aug 16, 2024	SELL	$2.25 - $4.17 $45,312 - $83,979	-20,139 Reduced 19.53%	82,994 $345,000
Q4 2023 Feb 13, 2024	BUY	$2.25 - $4.17 $21,717 - $40,248	9,652 Added 13.16%	82,994 $345,000
Q3 2023 Nov 15, 2023	BUY	$3.12 - $5.85 $38,737 - $72,633	12,416 Added 20.38%	73,342 $297,000
Q2 2023 Aug 14, 2023	BUY	$5.38 - $7.96 $92,078 - $136,235	17,115 Added 39.07%	60,926 $355,000
Q1 2023 May 15, 2023	BUY	$3.46 - $6.0 $5,148 - $8,928	1,488 Added 3.52%	43,811 $251,000
Q4 2022 Feb 14, 2023	SELL	$2.59 - $3.71 $821 - $1,176	-317 Reduced 0.74%	42,323 $152,000
Q3 2022 Nov 14, 2022	SELL	$3.1 - $4.8 $32,091 - $49,689	-10,352 Reduced 19.54%	42,640 $136,000
Q2 2022 Oct 27, 2022	BUY	$3.62 - $6.55 $33,332 - $60,312	9,208 Added 21.03%	52,992 $211,000
Q2 2022 Aug 15, 2022	BUY	$3.62 - $6.55 $33,332 - $60,312	9,208 Added 21.03%	52,992 $211,000
Q1 2022 Oct 27, 2022	SELL	$5.64 - $7.95 $51,933 - $73,203	-9,208 Reduced 17.38%	43,784 $280,000
Q1 2022 May 13, 2022	SELL	$5.64 - $7.95 $71,374 - $100,607	-12,655 Reduced 22.42%	43,784 $280,000
Q4 2021 Feb 14, 2022	SELL	$7.2 - $11.72 $118,051 - $192,161	-16,396 Reduced 22.51%	56,439 $437,000
Q3 2021 Nov 15, 2021	BUY	$8.44 - $12.65 $614,727 - $921,362	72,835 New	72,835 $760,000

Others Institutions Holding DCTH

# of Institutions

129

Shares Held

13.1M

Call Options Held

133K

Put Options Held

159K

View Full List

About DELCATH SYSTEMS, INC.

Ticker DCTH
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,597,680
Market Cap $76.8M
Description
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...

More about DCTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account